Macular Degeneration Association

Analysis

Macular Degeneration Association is a registered charity in United States, based in Sarasota, FL. It received its IRS tax-exemption ruling in August 2010, 16 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Macular Degeneration Association reported income of $3.7m and spending of $2.4m, leaving 34% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income grew from $3.3m to $3.7m (+11%), an average of +2.6% a year. The sharpest change came in the year to December 2020, when income dropped by 39%. Over the whole period it spent 64% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Macular Degeneration Association sits at the 77th percentile: it is larger than about 77% of them. Against every charity in United States with reported income it ranks in the 90th percentile, and in the 92nd percentile within FL. Charities of a similar size with the same main cause include Alpha Omega Veterans Services Inc ($3.7m), American Society for Clinical Pharmacology & Therapeutics ($3.7m) and Assessment & Treatment Alternatives Inc ($3.7m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 87% of the total. Compensation of current officers, directors and key employees was $425k (17% of expenses). Other salaries and wages came to $193k. It paid $30k in professional fundraising fees. At year end it held assets of $5.9m against liabilities of $174k, net assets of $5.7m. It reported 7 employees.